Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Ligand Pharma (LGND)

NASDAQ:LGND

LGND

Ligand Pharma

RESEARCH TOOLSreports

Ligand Pharma (LGND) Ratios

Compare

829 Followers

Ligand Pharma Ratios

LGND's free cash flow for Q3 2025 was $-0.59. For the 2025 fiscal year, LGND's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	24.69	8.93	14.15	2.67	11.15
Quick Ratio	24.30	8.55	12.72	2.53	10.50
Cash Ratio	21.76	1.95	1.37	<0.01	0.47
Solvency Ratio	0.08	0.28	1.03	0.23	0.21
Operating Cash Flow Ratio	1.81	2.61	2.95	1.40	1.89
Short-Term Operating Cash Flow Coverage	50.83	0.00	0.00	1.80	0.00
Net Current Asset Value	$ 227.32M	$ 220.22M	$ 151.13M	$ 98.42M	$ -15.00M
Leverage Ratios
Debt-to-Assets Ratio	0.31	<0.01	<0.01	0.12	0.26
Debt-to-Equity Ratio	0.47	<0.01	<0.01	0.15	0.41
Debt-to-Capital Ratio	0.32	<0.01	<0.01	0.13	0.29
Long-Term Debt-to-Capital Ratio	0.32	0.00	0.00	0.00	0.28
Financial Leverage Ratio	1.55	1.13	1.12	1.28	1.58
Debt Service Coverage Ratio	22.70	11.28	138.71	0.17	7.65
Interest Coverage Ratio	19.84	-7.44	18.20	-14.18	4.21
Debt to Market Cap	0.11	0.00	0.00	0.07	0.12
Interest Debt Per Share	23.33	0.55	0.39	5.31	21.35
Net Debt to EBITDA	-15.10	-1.60	-0.17	1.61	2.38
Profitability Margins
Gross Profit Margin	19.20%	93.37%	73.31%	73.08%	77.56%
EBIT Margin	-29.95%	3.32%	48.98%	19.27%	33.13%
EBITDA Margin	5.63%	24.41%	76.79%	27.72%	48.05%
Operating Profit Margin	6.97%	-13.53%	9.09%	-13.00%	28.47%
Pretax Profit Margin	25.07%	1.51%	48.48%	18.35%	17.07%
Net Profit Margin	14.26%	-2.41%	39.72%	-2.66%	20.62%
Continuous Operations Profit Margin	-12.37%	-2.41%	40.98%	-2.66%	27.55%
Net Income Per EBT	56.89%	-160.13%	81.93%	-14.49%	120.80%
EBT Per EBIT	359.43%	-11.14%	533.08%	-141.20%	59.95%
Return on Assets (ROA)	2.43%	-0.43%	6.63%	-0.68%	4.39%
Return on Equity (ROE)	4.21%	-0.49%	7.44%	-0.87%	6.95%
Return on Capital Employed (ROCE)	1.21%	-2.50%	1.55%	-3.84%	6.26%
Return on Invested Capital (ROIC)	1.80%	4.00%	1.31%	0.50%	7.62%
Return on Tangible Assets	3.14%	-0.71%	16.46%	-1.71%	10.27%
Earnings Yield	0.92%	-0.21%	4.22%	-0.46%	2.22%
Efficiency Ratios
Receivables Turnover	4.36	3.94	3.34	5.60	3.02
Payables Turnover	0.00	2.12	14.44	9.95	7.40
Inventory Turnover	3.62	0.78	1.46	3.97	2.28
Fixed Asset Turnover	22.68	6.74	5.24	13.08	8.46
Asset Turnover	0.17	0.18	0.17	0.26	0.21
Working Capital Turnover Ratio	0.50	0.65	0.68	0.67	0.67
Cash Conversion Cycle	184.35	385.42	333.61	120.35	231.79
Days of Sales Outstanding	83.63	92.70	109.27	65.17	120.70
Days of Inventory Outstanding	100.73	465.20	249.61	91.85	160.42
Days of Payables Outstanding	0.00	172.48	25.27	36.67	49.33
Operating Cycle	184.35	557.90	358.88	157.02	281.12
Cash Flow Ratios
Operating Cash Flow Per Share	2.86	5.31	2.87	8.17	4.74
Free Cash Flow Per Share	2.06	5.21	-0.25	7.11	4.21
CapEx Per Share	0.79	0.10	0.20	1.06	0.53
Free Cash Flow to Operating Cash Flow	0.72	0.98	-0.09	0.87	0.89
Dividend Paid and CapEx Coverage Ratio	3.60	53.29	14.08	7.69	8.99
Capital Expenditure Coverage Ratio	3.60	53.29	14.08	7.69	8.99
Operating Cash Flow Coverage Ratio	0.12	13.66	8.04	1.57	0.23
Operating Cash Flow to Sales Ratio	0.22	0.58	0.38	0.70	0.28
Free Cash Flow Yield	1.01%	4.86%	-0.35%	10.64%	2.73%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	108.84	-486.05	23.69	-215.90	44.96
Price-to-Sales (P/S) Ratio	15.77	11.73	9.41	5.74	9.27
Price-to-Book (P/B) Ratio	4.10	2.36	1.76	1.89	3.13
Price-to-Free Cash Flow (P/FCF) Ratio	99.14	20.58	-289.19	9.40	36.68
Price-to-Operating Cash Flow Ratio	70.45	20.19	24.92	8.17	32.60
Price-to-Earnings Growth (PEG) Ratio	0.67	4.53	-0.02	1.98	-0.02
Price-to-Fair Value	4.10	2.36	1.76	1.89	3.13
Enterprise Value Multiple	265.07	46.44	12.09	22.32	21.67
Enterprise Value	3.75B	1.89B	1.22B	1.21B	2.89B
EV to EBITDA	265.07	46.44	12.09	22.32	21.67
EV to Sales	14.92	11.34	9.28	6.19	10.41
EV to Free Cash Flow	93.80	19.90	-285.26	10.13	41.20
EV to Operating Cash Flow	67.73	19.52	24.58	8.81	36.62
Tangible Book Value Per Share	49.06	25.07	13.33	8.25	4.60
Shareholders’ Equity Per Share	49.06	45.40	40.52	35.42	49.41
Tax and Other Ratios
Effective Tax Rate	-0.49	2.60	0.15	1.14	-0.22
Revenue Per Share	12.97	9.14	7.59	11.63	16.66
Net Income Per Share	1.85	-0.22	3.02	-0.31	3.44
Tax Burden	0.57	-1.60	0.82	-0.14	1.21
Interest Burden	-0.84	0.45	0.99	0.95	0.52
Research & Development to Revenue	0.33	0.13	0.19	0.18	0.25
SG&A to Revenue	0.37	0.47	0.40	0.36	0.21
Stock-Based Compensation to Revenue	0.21	0.25	0.20	0.31	0.14
Income Quality	-0.73	-24.07	0.95	-4.13	1.38

Currency in USD